TY - JOUR
T1 - Time to Reaching Target Cooling Temperature and 2-year Outcomes in Infants with Hypoxic-Ischemic Encephalopathy
AU - Rao, Rakesh
AU - Comstock, Bryan A.
AU - Wu, Tai Wei
AU - Mietzsch, Ulrike
AU - Mayock, Dennis E.
AU - Gonzalez, Fernando F.
AU - Wood, Thomas R.
AU - Heagerty, Patrick J.
AU - Juul, Sandra E.
AU - Wu, Yvonne W.
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2024/3
Y1 - 2024/3
N2 - Objective: To determine if time to reaching target temperature (TT) is associated with death or neurodevelopmental impairment (NDI) at 2 years of age in infants with hypoxic-ischemic encephalopathy (HIE). Study design: Newborn infants ≥36 weeks of gestation diagnosed with moderate or severe HIE and treated with therapeutic hypothermia were stratified based on time at which TT was reached, defined as early (ie, ≤4 hours of age) or late (>4 hours of age). Primary outcomes were death or NDI. Secondary outcomes included neurodevelopmental assessment with Bayley Scales of Infant and Toddler Development, third edition (BSID-III) at age 2. Results: Among 500 infants, the median time to reaching TT was 4.3 hours (IWR, 3.2-5.7 hours). Infants in early TT group (n = 211 [42%]) compared with the late TT group (n = 289 [58%]) were more likely to be inborn (23% vs 13%; P < .001) and have severe HIE (28% vs 19%; P = .03). The early and late TT groups did not differ in the primary outcome of death or any NDI (adjusted RR, 1.05; 95% CI, 0.85-0.30; P = .62). Among survivors, neurodevelopmental outcomes did not differ significantly in the 2 groups (adjusted mean difference in Bayley Scales of Infant Development-III scores: cognitive, −2.8 [95% CI, −6.1 to 0.5], language −3.3 [95% CI, −7.4 to 0.8], and motor −3.5 [95% CI, −7.3 to 0.3]). Conclusions: In infants with HIE, time to reach TT is not independently associated with risk of death or NDI at age 2 years. Among survivors, developmental outcomes are similar between those who reached TT at <4 and ≥4 hours of age. Trial Registration: High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL); NCT02811263; https://beta.clinicaltrials.gov/study/NCT02811263.
AB - Objective: To determine if time to reaching target temperature (TT) is associated with death or neurodevelopmental impairment (NDI) at 2 years of age in infants with hypoxic-ischemic encephalopathy (HIE). Study design: Newborn infants ≥36 weeks of gestation diagnosed with moderate or severe HIE and treated with therapeutic hypothermia were stratified based on time at which TT was reached, defined as early (ie, ≤4 hours of age) or late (>4 hours of age). Primary outcomes were death or NDI. Secondary outcomes included neurodevelopmental assessment with Bayley Scales of Infant and Toddler Development, third edition (BSID-III) at age 2. Results: Among 500 infants, the median time to reaching TT was 4.3 hours (IWR, 3.2-5.7 hours). Infants in early TT group (n = 211 [42%]) compared with the late TT group (n = 289 [58%]) were more likely to be inborn (23% vs 13%; P < .001) and have severe HIE (28% vs 19%; P = .03). The early and late TT groups did not differ in the primary outcome of death or any NDI (adjusted RR, 1.05; 95% CI, 0.85-0.30; P = .62). Among survivors, neurodevelopmental outcomes did not differ significantly in the 2 groups (adjusted mean difference in Bayley Scales of Infant Development-III scores: cognitive, −2.8 [95% CI, −6.1 to 0.5], language −3.3 [95% CI, −7.4 to 0.8], and motor −3.5 [95% CI, −7.3 to 0.3]). Conclusions: In infants with HIE, time to reach TT is not independently associated with risk of death or NDI at age 2 years. Among survivors, developmental outcomes are similar between those who reached TT at <4 and ≥4 hours of age. Trial Registration: High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL); NCT02811263; https://beta.clinicaltrials.gov/study/NCT02811263.
KW - age at target temperature
KW - hypoxia-ischemia
KW - neonatal encephalopathy
UR - http://www.scopus.com/inward/record.url?scp=85181676079&partnerID=8YFLogxK
U2 - 10.1016/j.jpeds.2023.113853
DO - 10.1016/j.jpeds.2023.113853
M3 - Article
C2 - 38006967
AN - SCOPUS:85181676079
SN - 0022-3476
VL - 266
JO - Journal of Pediatrics
JF - Journal of Pediatrics
M1 - 113853
ER -